Integrated Filing — IndAS



General information about company

Scrip Code 544647
NSE Symbol NEPHROPLUS
MSEI Symbol NOTLISTED
ISIN INE428V01029
Name of company Nephrocare Health Services Limited
Type of company Main Board
Class of security Equity
Date of start of financial year 01-04-2026
Date of end of financial year 31-03-2027
Date of board meeting when results were approved 03-11-2026
Date on which prior intimation of the meeting for considering financial results was informed to the exchange 12-10-2026
Description of presentation currency INR
Level of rounding used in financial results Lakhs
Reporting Type Quarterly
Reporting Quarter Second quarter
Nature of report standalone or consolidated Standalone
Whether results are audited or unaudited for the quarter ended Unaudited
Whether results are audited or unaudited for the Year to date for current period ended/year ended Unaudited
Segment Reporting Single segment
Description of single segment Healthcare
Start date and time of board meeting 03-11-2026   16:00:00
End date and time of board meeting 03-11-2026   17:20:00
Whether cash flow statement is applicable on company Yes
Type of cash flow statement Cash Flow Indirect
Declaration of unmodified opinion or statement on impact of audit qualification Not applicable
Whether the company has any related party? Yes
Whether the company has entered into any Related Party transaction during the selected half year for which it wants to submit disclosure? Yes
(I) We declare that the acceptance of fixed deposits by the bans/Non-Banking Finance Company are at the terms uniformly applicable/offered to all shareholders/public NA
(II) We declare that the scheduled commercial bank, as per RBI circular RBI/DBR/2015-16/19 dated March 03, 2016, has allowed additional interest of one per cent per annum, over and above the rate of interest mentioned in the schedule of interest rates on savings or a term deposits of banks staff and their exclusive associations as well as on deposits of Chairman, Chairman & Managing Director, Executive Director or such other Executives appointed for a fixed tenure. NA
Whether the company is a high value debt listed entity according to regulation 15 (1A)? No
(a) If answer to above question is Yes, whether complying with proviso to regulation 23 (9), i.e., submitting RPT disclosures on the day of results publication?
(b) If answer to above question is No, please explain the reason for not complying.
Whether the updated Related Party Transactions (RPT) Policy (in compliance with Reg. 23 of SEBI LODR) has been uploaded on the website of the Company? Yes
Latest Date on which RPT policy is updated 19-05-2026
Indicate Company website link for updated RPT policy of the Company https://nephroplus.com/api/assets/investors/corporate-governance/policies-and-code-of-conduct/documents/20260512_NephroPlus_Revised_RPT_policy_-_v2_updated.pdf
Whether statement on deviation or variation for proceeds of public issue, rights issue, preferential issue, qualified institutions placement etc. is applicable to the company for the current quarter? Yes
No. of times funds raised during the quarter 1
Whether the disclosure for the Default on Loans and Debt Securities is applicable to the entity? No
No Default as on date.



Financial Results Ind-AS

Amount in (Lakhs)

Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-07-2026 01-04-2026
B Date of end of reporting period 30-09-2026 30-09-2026
C Whether results are audited or unaudited Unaudited Unaudited
D Nature of report standalone or consolidated Standalone Standalone
1 Income
Revenue from operations 17,657.90 34,695.70
Other income 608.30 1,212.90
Total income 18,266.20 35,908.60
2 Expenses
(a) Cost of materials consumed 4,290.70 8,508.30
(b) Purchases of stock-in-trade 0.00 0.00
(c) Changes in inventories of finished goods, work-in-progress and stock-in-trade 0.00 0.00
(d) Employee benefit expense 3,459.00 6,539.20
(e) Finance costs 67.40 115.90
(f) Depreciation, depletion and amortisation expense 1,350.50 2,659.30
(f) Other Expenses
1 Healthcare professional fees 2,102.20 4,319.40
2 Hospital fees 2,017.50 3,807.50
3 Other expenses 3,287.80 6,598.60
Total other expenses 7,407.50 14,725.50
Total expenses 16,575.10 32,548.20
3 Total profit before exceptional items and tax 1,691.10 3,360.40
4 Exceptional items 0.00 0.00
5 Total profit before tax 1,691.10 3,360.40
6 Tax expense
7 Current tax 407.60 1,014.70
8 Deferred tax (147.30) (341.40)
9 Total tax expenses 260.30 673.30
10 Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement 0.00 0.00
11 Net Profit Loss for the period from continuing operations 1,430.80 2,687.10
12 Profit (loss) from discontinued operations before tax 0.00 0.00
13 Tax expense of discontinued operations 0.00 0.00
14 Net profit (loss) from discontinued operation after tax 0.00 0.00
15 Share of profit (loss) of associates and joint ventures accounted for using equity method 0.00 0.00
16 Total profit (loss) for period 1,430.80 2,687.10
17 Other comprehensive income net of taxes (24.70) (23.40)
18 Total Comprehensive Income for the period 1,406.10 2,663.70
19 Total profit or loss, attributable to
Profit or loss, attributable to owners of parent
Total profit or loss, attributable to non-controlling interests
20 Total Comprehensive income for the period attributable to
Comprehensive income for the period attributable to owners of parent
Total comprehensive income for the period attributable to owners of parent non-controlling interests
21 Details of equity share capital
Paid-up equity share capital 2,011.20 2,011.20
Face value of equity share capital 2 2
27 Details of debt securities
22 Reserves excluding revaluation reserve
23 Earnings per share
i Earnings per equity share for continuing operations
Basic earnings (loss) per share from continuing operations 1.42 2.68
Diluted earnings (loss) per share from continuing operations 1.39 2.61
ii Earnings per equity share for discontinued operations
Basic earnings (loss) per share from discontinued operations 0 0
Diluted earnings (loss) per share from discontinued operations 0 0
ii Earnings per equity share
Basic earnings (loss) per share from continuing and discontinued operations 1.42 2.68
Diluted earnings (loss) per share from continuing and discontinued operations 1.39 2.61
24 Debt equity ratio
25 Debt service coverage ratio
26 Interest service coverage ratio
27 Disclosure of notes on financial results Textual Information(1)



Disclosure of notes on financial results

Textual Information(1) Notes: 1. The above unaudited standalone financial results of Nephrocare Health Services Limited (formerly Nephrocare Health Services Private Limited) (the Company) for the quarter and half-year ended 30 September 2026, have been prepared in accordance with the Indian Accounting Standard (referred to as 'Ind AS') prescribed under Section 133 of the Companies Act, 2013 read with Companies (Indian Accounting Standards) Rules, 2015, as amended from time to time and in terms of Regulation 33 of the Securities Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. 2. These unaudited standalone financial results have been reviewed by the Audit Committee and approved by the Board of Directors at their respective meetings held on 03 November 2026. The Statutory auditors of the Company have conducted a 'Limited Review' of the standalone financial results and have issued an unmodified review conclusion thereon. 3. The Company was listed on the stock exchanges on 17 December 2025. Accordingly, the standalone financial results for the corresponding quarter ended 30 September 2025 were not required to be submitted to the stock exchanges under Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and were consequently not subjected to audit or limited review by the statutory auditors. The comparative figures for the quarter ended 30 September 2025 as included in these standalone financial results, have been approved by the Board of Directors of the Company. 4. In accordance with Ind AS 108, Operating segments, segment information has been provided in the consolidated financial results of the Company and no separate disclosure on segment information is given in these unaudited standalone financial results. 5. During the year ended 31 March 2026, the Company has completed an initial public offering (IPO) of 18,943,020 equity shares with a face value of INR 2 each at an issue price of INR 460 per share, comprising fresh issue of 7,689,918 shares and an offer for sale of 11,253,102 shares. The Company’s equity shares were listed on the National Stock Exchange of India Limited (NSE) and BSE Limited (BSE) on 17 December 2025. The utilisation of net IPO proceeds is summarised below: Objectives Capital expenditure for opening new dialysis clinics in India Pre-payment, or scheduled repayment, in full or part, of certain borrowings availed General corporate purposes Total (Rs. in Millions) Amount to be utilised as per prospectus Utilisation up to 30 Sep 2026 Unutilised as on 30 Sep 2026 1,291.06 187.39 1,103.67 1,359.99 1,359.99 - 600.48 6 00.47 0.01 3,251.53 2,147.85 1,103.68 6. The unaudited financial results of the following subsidiaries, step-down subsidiaries and joint venture of the Company are included in the consolidated financial results for the quarter and half-year ended 30 September 2026. a) Subsidiaries (including step-down subsidiaries): 1) Nephrocare Health Services Central Asia FE LLC 2) Nephrocare Health Services Nepal Private Limited 3) Nephrocare Health Services International Pte Ltd 4) Nephro Plus Kidney Services Company 5) Nephrocare Health Care Services, Philippines Inc. 6) Anram Medical Group Inc. 7) Cadiz Dialysis Hub Inc. 8) Dialysis Asia and Patient Care Center Inc. 9) People’s Center For Hemodialysis Care Inc. 10) Curis Hemodialysis Clinic Inc. 11) Mega Health Dialysis Center Inc. 12) Universe Dialysis and Kidney Care Centre Inc. 13) St. Margareth Dialysis and Biocare Centre Inc. 14) Medical Experts Group and Associates Inc. 15) Curis Cavite Renal Corporation 16) Renal Therapy Solutions, Inc. 17) Rizal Dialysis and Wellness Centre OPC 18) Bioregen Hemo Center Inc. 19) Carmona Dialysis System Inc. 20) Infini Care Health Systems Inc. 21) Kolff Dialysis Inc. 22) AIZ Hemodialysis Centre Inc. 23) Nephro Alliance Ventures Inc. 24) Nephroplus Health Services Kazakhstan Limited Liability Partnership (LLP) ( w.e.f. 26 May 2026) 25) Dialysis Center Almaty LLP ( w.e.f. 01 September 2026) b) Joint Venture 1) Nephrocare Health Services Saudi Arabia Company 7. During the half year ended September 30, 2026, the Company has issued 2,18,297 equity shares of INR 2 each to eligible employees of the Company against the exercise of options given under Employees Stock Grant Scheme for an aggregate value of INR 0.44 million. 8. During the half year ended September 30, 2026, under the Employee Stock Grant Scheme i.e., ESOP Scheme 2026, the Company has granted 4,01,362 stock grants to eligible employees of the Company. Upon vesting, as per the Scheme, equivalent number of equity shares of nominal value of INR 2 each in the Company shall be issued to the eligible employees on exercising their grants. 9. The unaudited standalone financial results for the quarter and half-year ended 30 September 2026, are available on the BSE Limited website (URL: www.bseindia.com), the National Stock Exchange of India Limited website (URL: nseindia.com) and on the Company's website (URL: https://nephroplus.com/investors).



Remarks

Debt equity ratio
Debt service coverage ratio
Interest service coverage ratio


Statement of Asset and Liabilities

Amount in (Lakhs)

Particulars Year ended (dd-mm-yyyy)
Date of start of reporting period 01-04-2026
Date of end of reporting period 30-09-2026
Whether results are audited or unaudited Unaudited
Nature of report standalone or consolidated Standalone
Assets
1 Non-current assets
Property, plant and equipment 22,231.60
Capital work-in-progress 598.30
Investment property 0.00
Goodwill 0.00
Other intangible assets 189.20
Intangible assets under development 13.40
Biological assets other than bearer plants 0.00
Investments accounted for using equity method 0.00
Non-current financial assets
Non-current investments 16,468.40
Trade receivables, non-current 0.00
Loans, non-current 0.00
Other non-current financial assets
1 Other financial assets 497.30
Total of other non-current financial assets 497.30
Total non-current financial assets 16,965.70
Deferred tax assets (net) 3,128.90
Other non-current assets
1 Right-of-use assets 2,127.40
2 Other tax assets (net) 322.70
3 Other non-current assets 453.10
Total of other non-current assets 2,903.20
Total non-current assets 46,030.30
2 Current assets
Inventories 2,684.90
Current financial asset
Current investments 20,475.00
Trade receivables, current 22,555.60
Cash and cash equivalents 17,613.30
Bank balance other than cash and cash equivalents 3,135.20
Loans, current 0.00
Other current financial assets
Total of other current financial assets 1,022.10
Total current financial assets 64,801.20
Current tax assets (net) 0.00
Other current assets
1 Other current assets 729.50
Total of other current assets 729.50
Total current assets 68,215.60
3 Non-current assets classified as held for sale 0.00
4 Regulatory deferral account debit balances and related deferred tax Assets 0.00
Total assets 1,14,245.90
Equity and liabilities
1 Equity
Equity attributable to owners of parent
Equity share capital 2,011.20
Other equity 98,258.50
Total equity attributable to owners of parent 1,00,269.70
Non controlling interest
Total equity 1,00,269.70
2 Liabilities
Non-current liabilities
Non-current financial liabilities
Borrowings, non-current 0.00
Trade payables, non-current
(A) Total outstanding dues of micro enterprises and small enterprises 0.00
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises 0.00
Total Trade payable 0.00
Other non-current financial liabilities
1 Lease liabilities 643.20
2 Other financial liabilities 43.40
Total of other non-current financial liabilities 686.60
Total non-current financial liabilities 686.60
Provisions, non-current 660.90
Deferred tax liabilities (net) 0.00
Deferred government grants, Non-current 0.00
Other non-current liabilities
Total of other non-current liabilities
Total non-current liabilities 1,347.50
Current liabilities
Current financial liabilities
Borrowings, current 806.90
Trade payables, current
(A) Total outstanding dues of micro enterprises and small enterprises 2,156.30
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises 7,110.80
Total Trade payable 9,267.10
Other current financial liabilities
1 Lease liabilities 215.20
2 Other financial liabilities 1,960.40
Total of other current financial liabilities 2,175.60
Total current financial liabilities 12,249.60
Other current liabilities 159.90
1 Other current liabilities 159.90
Total of other current liabilities 159.90
Provisions, current 219.20
Current tax liabilities (Net) 0.00
Deferred government grants, Current 0.00
Total current liabilities 12,628.70
3 Liabilities directly associated with assets in disposal group classified as held for sale 0.00
4 Regulatory deferral account credit balances and related deferred tax liability 0.00
Total liabilities 13,976.20
Total equity and liabilites 1,14,245.90
Disclosure of notes on assets and liabilities



Format for Reporting Segment wise Revenue, Results and Capital Employed along with the company results

Amount in (Lakhs)

Particulars 3 months/ 6 month ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
Date of start of reporting period 01-07-2026 01-04-2026
Date of end of reporting period 30-09-2026 30-09-2026
Whether results are audited or unaudited Unaudited Unaudited
Nature of report standalone or consolidated Standalone Standalone
1 Segment Revenue (Income)
(net sale/income from each segment should be disclosed)
Total Segment Revenue
Less: Inter segment revenue
Revenue from operations
2 Segment Result
Profit (+) / Loss (-) before tax and interest from each segment
Total Profit before tax
i. Finance cost
ii. Other Unallocable Expenditure net off Unallocable income
Profit before tax
3 (Segment Asset - Segment Liabilities)
Segment Asset
Total Segment Asset
Un-allocable Assets null null
Net Segment Asset null null
4 Segment Liabilities
Segment Liabilities
Total Segment Liabilities
Un-allocable Liabilities null null
Net Segment Liabilities null null
Disclosure of notes on segments



Other Comprehensive Income

Amount in (Lakhs)

Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-07-2026 01-04-2026
B Date of end of reporting period 30-09-2026 30-09-2026
C Whether results are audited or unaudited Unaudited Unaudited
D Nature of report standalone or consolidated Standalone Standalone
Other comprehensive income [Abstract]
1 Amount of items that will not be reclassified to profit and loss
1 Remeasurement gain / (loss) on defined benefit plans (33.00) (31.30)
2 Income tax relating to items above 8.30 7.90
Total Amount of items that will not be reclassified to profit and loss (24.70) (23.40)
2 Income tax relating to items that will not be reclassified to profit or loss 0.00 0.00
3 Amount of items that will be reclassified to profit and loss
Total Amount of items that will be reclassified to profit and loss
4 Income tax relating to items that will be reclassified to profit or loss
5 Total Other comprehensive income (24.70) (23.40)



Cash flow statement, indirect

Amount in (Lakhs)

Particulars Year ended (dd-mm-yyyy)
A Date of start of reporting period 01-04-2026
B Date of end of reporting period 30-09-2026
C Whether results are audited or unaudited Unaudited
D Nature of report standalone or consolidated Standalone
Statement of cash flows
Cash flows from used in operating activities
Profit before tax 3,360.40
Adjustments for reconcile profit (loss)
Adjustments for finance costs 115.90
Adjustments for decrease (increase) in inventories (872.20)
Adjustments for decrease (increase) in trade receivables, current (1,664.70)
Adjustments for decrease (increase) in trade receivables, non-current 0.00
Adjustments for decrease (increase) in other current assets (387.00)
Adjustments for decrease (increase) in other non-current assets 0.00
Adjustments for other financial assets, non-current 0.00
Adjustments for other financial assets, current (31.40)
Adjustments for other bank balances 0.00
Adjustments for increase (decrease) in trade payables, current 807.10
Adjustments for increase (decrease) in trade payables, non-current 0.00
Adjustments for increase (decrease) in other current liabilities (174.20)
Adjustments for increase (decrease) in other non-current liabilities 0.00
Adjustments for depreciation and amortisation expense 2,659.30
Adjustments for impairment loss reversal of impairment loss recognised in profit or loss 0.00
Adjustments for provisions, current 71.00
Adjustments for provisions, non-current 0.00
Adjustments for other financial liabilities, current (1,043.70)
Adjustments for other financial liabilities, non-current 0.00
Adjustments for unrealised foreign exchange losses gains 0.00
Adjustments for dividend income 0.00
Adjustments for interest income 519.90
Adjustments for share-based payments 307.20
Adjustments for fair value losses (gains) (541.10)
Adjustments for undistributed profits of associates 0.00
Other adjustments for which cash effects are investing or financing cash flow 0.00
Other adjustments to reconcile profit (loss) 0.00
Other adjustments for non-cash items 940.40
Share of profit and loss from partnership firm or association of persons or limited liability partnerships 0.00
Total adjustments for reconcile profit (loss) (333.30)
Net cash flows from (used in) operations 3,027.10
Dividends received 0.00
Interest paid 0.00
Interest received 0.00
Income taxes paid (refund) 912.30
Other inflows (outflows) of cash 0.00
Net cash flows from (used in) operating activities 2,114.80
Cash flows from used in investing activities
Cash flows from losing control of subsidiaries or other businesses 0.00
Cash flows used in obtaining control of subsidiaries or other businesses 0.00
Other cash receipts from sales of equity or debt instruments of other entities 0.00
Other cash payments to acquire equity or debt instruments of other entities 0.00
Other cash receipts from sales of interests in joint ventures 0.00
Other cash payments to acquire interests in joint ventures 0.00
Cash receipts from share of profits of partnership firm or association of persons or limited liability partnerships 0.00
Cash payment for investment in partnership firm or association of persons or limited liability partnerships 0.00
Proceeds from sales of property, plant and equipment 5.70
Purchase of property, plant and equipment 2,874.20
Proceeds from sales of investment property 0.00
Purchase of investment property 0.00
Proceeds from sales of intangible assets 0.00
Purchase of intangible assets 13.40
Proceeds from sales of intangible assets under development 0.00
Purchase of intangible assets under development 0.00
Proceeds from sales of goodwill 0.00
Purchase of goodwill 0.00
Proceeds from biological assets other than bearer plants 0.00
Purchase of biological assets other than bearer plants 0.00
Proceeds from government grants 0.00
Proceeds from sales of other long-term assets 0.00
Purchase of other long-term assets 0.00
Cash advances and loans made to other parties 0.00
Cash receipts from repayment of advances and loans made to other parties 0.00
Cash payments for future contracts, forward contracts, option contracts and swap contracts 0.00
Cash receipts from future contracts, forward contracts, option contracts and swap contracts 0.00
Dividends received 0.00
Interest received 564.70
Income taxes paid (refund) 0.00
Other inflows (outflows) of cash 10,497.50
Net cash flows from (used in) investing activities 8,180.30
Cash flows from used in financing activities
Proceeds from changes in ownership interests in subsidiaries 0.00
Payments from changes in ownership interests in subsidiaries 0.00
Proceeds from issuing shares 208.20
Proceeds from issuing other equity instruments 0.00
Payments to acquire or redeem entity's shares 0.00
Payments of other equity instruments 0.00
Proceeds from exercise of stock options 0.00
Proceeds from issuing debentures notes bonds etc 0.00
Proceeds from borrowings 556.10
Repayments of borrowings 6.80
Payments of lease liabilities 140.60
Dividends paid 0.00
Interest paid 74.90
Income taxes paid (refund) 0.00
Other inflows (outflows) of cash (2,591.60)
Net cash flows from (used in) financing activities (2,049.60)
Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes 8,245.50
Effect of exchange rate changes on cash and cash equivalents
Effect of exchange rate changes on cash and cash equivalents 0.00
Net increase (decrease) in cash and cash equivalents 8,245.50
Cash and cash equivalents cash flow statement at beginning of period 9,367.80
Cash and cash equivalents cash flow statement at end of period 17,613.30





Statement on Deviation or Variation for proceeds of Public Issue, Rights Issue, Preferential Issue, Qualified Institutions Placement Etc. (1)

Amount in (Lakhs)

Mode of Fund Raising Public Issues
Description of mode of fund raising (Applicable in case of others is selected)
Date of Raising Funds 17-12-2025
Amount Raised 35,340.50
Report filed for Quarter ended 30-09-2026
Monitoring Agency Applicable
Monitoring Agency Name, if applicable Crisil Ratings Limited
Is there a Deviation / Variation in use of funds raised No
If yes, whether the same is pursuant to change in terms of a contract or objects, which was approved by the shareholders
If Yes, Date of shareholder Approval
Explanation for the Deviation / Variation
Comments of the Audit Committee after review
Comments of the auditors, if any
Sr. Original Object Modified Object, if any Original Allocation Modified allocation, if any Funds Utilised Amount of Deviation/Variation for the quarter according to applicable object Remarks if any
1 Capital expenditure by the Company for opening new dialysis clinics in India Nil 12,910.60 0.00 1,873.90 0.00
2 Pre-payment, or scheduled repayment, in full or part, of certain borrowings availed by the Company Nil 13,599.90 0.00 13,599.90 0.00
3 General corporate purposes Nil 6,004.80 0.00 6,004.70 0.00
4 Issue expenses Nil 2,825.20 0.00 2,414.10 0.00


Signatory Details

Name of signatory Kishore Kathri
Designation of person Company Secretary and Compliance Officer
Place Hyderabad
Date 03-11-2026




Amount in (Lakhs)

Format for Disclosure of Related Party Transactions (applicable only for half-yearly filings i.e., 2nd and 4th quarter)

Sr No. Additional disclosure of related party transactions - applicable only in case the related party transaction relates to loans, inter-corporate deposits, advances or investments made or given by the listed entity/subsidiary. These details need to be disclosed only once, during the reporting period when such transaction was undertaken.
Details of the party (listed entity/subsidiary) entering into the transaction Details of the counterparty Type of related party transaction Details of other related party transaction Value of the related party transaction as approved by the audit committee Remarks on approval by audit committee Value of the related party transaction ratified by the audit committee Date of Audit Committee Meeting where the ratification was approved Value of transaction during the reporting period In case monies are due to either party as a result of the transaction In case any financial indebtedness is incurred to make or give loans, inter-corporate deposits, advances or investments Details of the loans, inter-corporate deposits, advances or investments Notes
Name PAN Name PAN Relationship of the counterparty with the listed entity or its subsidiary Opening balance Closing balance Nature of indebtedness (loan/ issuance of debt/ any other etc.) Details of other indebtedness Cost Tenure Nature (loan/ advance/ intercorporate deposit/ investment ) Interest Rate (%) Tenure Secured/ unsecured Purpose for which the funds will be utilised by the ultimate recipient of funds (endusage)
1 Nephrocare Health Services Limited (“NephroPlus”) Vikram Vuppala Chairman & Managing Director Remuneration NA 158.10 191.70 0.00
2 NephroPlus Rohit Singh Group Chief Executive Officer Remuneration NA 79.50 50.30 0.00
3 NephroPlus Prashant VinodKumar Goenka Group Chief Financial Officer Remuneration NA 92.50 45.00 0.00
4 NephroPlus Kishore Kathri Company Secretary and Compliance Officer Remuneration NA 17.10 8.80 0.00
5 NephroPlus Om Prakash Manchanda Independent Director Any other transaction Directors’ sitting fees NA 7.50 3.00 1.00
6 NephroPlus Hemant Sultania Independent Director Any other transaction Directors’ sitting fees NA 8.00 3.00 1.50
7 NephroPlus Annette Kumlien Independent Director Any other transaction Directors’ sitting fees NA 8.00 4.00 1.50
8 NephroPlus Ajay Bakshi Independent Director Any other transaction Directors’ sitting fees NA 7.50 6.00 0.00
9 NephroPlus Achala Health Services Private Limited Mr. Vikram Vuppala, Promoter and Chairman & Managing Director is member of AHSPL holding 600 equity shares Purchase of goods or services 500.00 Approved 71.60 0.00 8.90
10 NephroPlus Neuranceai Technologies Private Limited Mr. Ajay Bakshi, Independent Director is a Director of NTPL. Purchase of goods or services 100.00 Approved 10.50 0.00 0.00
11 NephroPlus AIZ Hemodialysis Centre Inc. Step down subsidiary Any other transaction Royalty 100.00 Approved 8.80 0.00 0.00
12 NephroPlus Bioregen Hemo Center Inc. Step down subsidiary Any other transaction Royalty 100.00 Approved 18.00 0.00 0.00
13 NephroPlus Cadiz Dialysis Hub Inc. Step down subsidiary Any other transaction Royalty 100.00 Approved 28.00 0.00 0.00
14 NephroPlus Carmona Dialysis System Inc. Step down subsidiary Any other transaction Royalty 100.00 Approved 21.00 0.00 0.00
15 NephroPlus Curis Cavite Renal Corporation Step down subsidiary Any other transaction Royalty 100.00 Approved 30.70 0.00 0.00
16 NephroPlus Curis Hemodialysis Clinic Inc. Step down subsidiary Any other transaction Royalty 100.00 Approved 23.10 0.00 0.00
17 NephroPlus Infini Care Health Systems Inc. Step down subsidiary Any other transaction Royalty 100.00 Approved 12.10 0.00 0.00
18 NephroPlus Kolff Dialysis Inc. Step down subsidiary Any other transaction Royalty 100.00 Approved 47.40 0.00 0.00
19 NephroPlus Medical Experts Group and Associates Inc. Step down subsidiary Any other transaction Royalty 100.00 Approved 20.50 0.00 0.00
20 NephroPlus Mega Health Dialysis Center Inc. Step down subsidiary Any other transaction Royalty 100.00 Approved 17.30 0.00 0.00
21 NephroPlus Nephro Alliance Ventures Inc. Step down subsidiary Any other transaction Royalty 100.00 Approved 35.30 0.00 0.00
22 NephroPlus Nephrocare Health Care Services, Philippines Inc. Step down subsidiary Any other transaction Guarantee commission 100.00 Approved 5.40 0.00 0.00
23 NephroPlus Nephrocare Health Care Services, Philippines Inc. Step down subsidiary Any other transaction Management fee 1,500.00 Approved 572.90 0.00 0.00
24 NephroPlus Nephrocare Health Care Services, Philippines Inc. Step down subsidiary Any other transaction Royalty 1,140.00 Approved 629.40 0.00 0.00
25 NephroPlus Nephrocare Health Services Central Asia Wholly owned subsidiary Any other transaction Guarantee commission 100.00 Approved 3.00 0.00 0.00
26 NephroPlus Nephrocare Health Services Central Asia Wholly owned subsidiary Any other transaction Management fee 390.00 Approved 243.10 0.00 0.00
27 NephroPlus Nephrocare Health Services Central Asia Wholly owned subsidiary Any other transaction Referral fee 1,510.00 Approved 660.20 0.00 0.00
28 NephroPlus Nephrocare Health Services Central Asia Wholly owned subsidiary Any other transaction Royalty 100.00 Approved 396.10 0.00 0.00
29 NephroPlus Nephrocare Health Services International Pte, Singapore Wholly owned subsidiary Any other transaction Guarantee commission 7.10 Approved 7.10 0.00 0.00
30 NephroPlus Nephrocare Health Services International Pte, Singapore Wholly owned subsidiary Any other transaction Management fee 100.00 Approved 0.10 0.00 0.00
31 NephroPlus Nephrocare Health Services Nepal Pvt Ltd Wholly owned subsidiary Any other transaction Management fee 100.00 Approved 0.00 0.00 0.00
32 NephroPlus Nephrocare Health Services Nepal Pvt Ltd Wholly owned subsidiary Any other transaction Royalty 100.00 Approved 0.00 0.00 0.00
33 NephroPlus Nephrocare Health Services Saudi Arabia Joint Venture Any other transaction Management fee 100.00 Approved 13.70 0.00 0.00
34 NephroPlus People's Center For Hemodialysis Care Inc. Step down subsidiary Any other transaction Royalty 100.00 Approved 24.60 0.00 0.00
35 NephroPlus Renal Therapy Solutions Inc Step down subsidiary Any other transaction Royalty 630.00 Approved 224.00 0.00 0.00
36 NephroPlus Rizal dialysis and wellness centre OPC Step down subsidiary Any other transaction Royalty 100.00 Approved 22.80 0.00 0.00
37 NephroPlus Universe Dialysis and Kidney Care Center Inc. Step down subsidiary Any other transaction Royalty 100.00 Approved 20.60 0.00 0.00
38 AIZ Hemodialysis Center Inc. Nephrocare Health Care Services Phils, Inc. Holding company Sale of goods or services NA 0.10 0.00 0.00
39 AIZ Hemodialysis Center Inc. Universe Kidney Care Center, Inc. Fellow subsidiary Sale of goods or services NA 0.40 0.00 0.00
40 AIZ Hemodialysis Center Inc. Kolff Dialysis Inc. Fellow subsidiary Sale of goods or services NA 0.30 0.00 0.00
41 Bioregen Hemo Center Inc. Nephrocare Health Care Services Phils, Inc. Holding company Sale of goods or services NA 2.50 0.00 0.00
42 Bioregen Hemo Center Inc. Infini Care Health Systems Inc. Fellow subsidiary Sale of goods or services NA 0.70 0.00 0.00
43 Curis Cavite Renal Corporation Nephrocare Health Care Services, Philippines Inc. Holding company Sale of goods or services NA 3.60 0.00 0.00
44 Curis Cavite Renal Corporation Mega Health Dialysis Center, Inc. Fellow subsidiary Sale of goods or services NA 0.00 0.00 0.00
45 Curis Cavite Renal Corporation Carmona Dialysis System Inc. Fellow subsidiary Sale of goods or services NA 0.70 0.00 0.00
46 Cadiz Dialysis Hub, Inc. Renal Therapy Solutions, Inc. Fellow subsidiary Sale of goods or services NA 3.70 0.00 0.00
47 Curis Hemodialysis Clinic, Inc. Nephrocare Health Care Services, Philippines Inc. Holding company Sale of goods or services NA 1.60 0.00 0.00
48 Carmona Dialysis System Inc. Nephrocare Health Care Services, Philippines Inc. Holding company Sale of goods or services NA 10.10 0.00 0.00
49 Carmona Dialysis System Inc. Universe Kidney Care Center, Inc. Fellow subsidiary Sale of goods or services NA 0.10 0.00 0.00
50 Carmona Dialysis System Inc. Mega Health Dialysis Center, Inc. Fellow subsidiary Sale of goods or services NA 0.70 0.00 0.00
51 Carmona Dialysis System Inc. Curis Cavite Renal Corporation Fellow subsidiary Sale of goods or services NA 1.20 0.00 0.00
52 Carmona Dialysis System Inc. Kolff Dialysis Inc. Fellow subsidiary Sale of goods or services NA 0.60 0.00 0.00
53 Infini Care Health Systems Inc. Nephrocare Health Care Services, Philippines Inc. Holding company Sale of goods or services NA 3.70 0.00 0.00
54 Infini Care Health Systems Inc. Curis Hemodialysis Clinic, Inc. Fellow subsidiary Sale of goods or services NA 0.90 0.00 0.00
55 Infini Care Health Systems Inc. Bioregen Hemo Center Inc. Fellow subsidiary Sale of goods or services NA 0.30 0.00 0.00
56 Kolff Dialysis Inc. Nephrocare Health Care Services, Philippines Inc. Holding company Sale of goods or services NA 0.50 0.00 0.00
57 Kolff Dialysis Inc. Universe Kidney Care Center, Inc. Fellow subsidiary Sale of goods or services NA 0.20 0.00 0.00
58 Kolff Dialysis Inc. AIZ Hemodialysis Center Inc. Fellow subsidiary Sale of goods or services NA 0.30 0.00 0.00
59 Medical Experts Group and Associates, Inc. Nephrocare Health Care Services, Philippines Inc. Holding company Sale of goods or services NA 9.10 0.00 0.00
60 Medical Experts Group and Associates, Inc. People's Center for Hemodialysis Care, Inc. Fellow subsidiary Sale of goods or services NA 0.00 0.00 0.00
61 Medical Experts Group and Associates, Inc. Renal Therapy Solutions, Inc. Fellow subsidiary Sale of goods or services NA 0.00 0.00 0.00
62 Medical Experts Group and Associates, Inc. Rizal Dialysis and Wellness Center, Inc. Fellow subsidiary Sale of goods or services NA 1.10 0.00 0.00
63 Mega Health Dialysis Center, Inc. Nephrocare Health Care Services, Philippines Inc. Holding company Sale of goods or services NA 5.40 0.00 0.00
64 Mega Health Dialysis Center, Inc. Universe Kidney Care Center, Inc. Fellow subsidiary Sale of goods or services NA 0.70 0.00 0.00
65 Mega Health Dialysis Center, Inc. Curis Cavite Renal Corporation Fellow subsidiary Sale of goods or services NA 0.90 0.00 0.00
66 Mega Health Dialysis Center, Inc. Carmona Dialysis System Inc. Fellow subsidiary Sale of goods or services NA 0.30 0.00 0.00
67 Mega Health Dialysis Center, Inc. Kolff Dialysis Inc. Fellow subsidiary Sale of goods or services NA 0.90 0.00 0.00
68 Nephro Alliance Ventures, Inc. Nephrocare Health Care Services, Philippines Inc. Holding company Sale of goods or services NA 7.50 0.00 0.00
69 Nephrocare Health Care Services, Philippines Inc. Cadiz Dialysis Hub, Inc. Wholly owned subsidiary Sale of goods or services NA 24.40 0.00 0.00
70 Nephrocare Health Care Services, Philippines Inc. People's Center for Hemodialysis Care, Inc. Wholly owned subsidiary Sale of goods or services NA 60.10 0.00 0.00
71 Nephrocare Health Care Services, Philippines Inc. Curis Hemodialysis Clinic, Inc. Wholly owned subsidiary Sale of goods or services NA 38.40 0.00 0.00
72 Nephrocare Health Care Services, Philippines Inc. Universe Kidney Care Center, Inc. Wholly owned subsidiary Sale of goods or services NA 41.40 0.00 0.00
73 Nephrocare Health Care Services, Philippines Inc. Mega Health Dialysis Center, Inc. Wholly owned subsidiary Sale of goods or services NA 36.70 0.00 0.00
74 Nephrocare Health Care Services, Philippines Inc. Medical Experts Group and Associates, Inc. Wholly owned subsidiary Sale of goods or services NA 41.50 0.00 0.00
75 Nephrocare Health Care Services, Philippines Inc. Curis Cavite Renal Corporation Wholly owned subsidiary Sale of goods or services NA 75.00 0.00 0.00
76 Nephrocare Health Care Services, Philippines Inc. Renal Therapy Solutions, Inc. Wholly owned subsidiary Sale of goods or services NA 279.80 0.00 0.00
77 Nephrocare Health Care Services, Philippines Inc. Rizal Dialysis and Wellness Center, Inc. Wholly owned subsidiary Sale of goods or services NA 38.40 0.00 0.00
78 Nephrocare Health Care Services, Philippines Inc. AIZ Hemodialysis Center Inc. Wholly owned subsidiary Sale of goods or services NA 12.20 0.00 0.00
79 Nephrocare Health Care Services, Philippines Inc. Bioregen Hemo Center Inc. Wholly owned subsidiary Sale of goods or services NA 32.10 0.00 0.00
80 Nephrocare Health Care Services, Philippines Inc. Carmona Dialysis System Inc. Wholly owned subsidiary Sale of goods or services NA 34.20 0.00 0.00
81 Nephrocare Health Care Services, Philippines Inc. Infini Care Health Systems Inc. Wholly owned subsidiary Sale of goods or services NA 22.70 0.00 0.00
82 Nephrocare Health Care Services, Philippines Inc. Kolff Dialysis Inc. Wholly owned subsidiary Sale of goods or services NA 61.10 0.00 0.00
83 Nephrocare Health Care Services, Philippines Inc. Nephro Alliance Ventures, Inc. Wholly owned subsidiary Sale of goods or services NA 46.10 0.00 0.00
84 People's Center for Hemodialysis Care, Inc. Nephrocare Health Care Services, Philippines Inc. Holding company Sale of goods or services NA 3.00 0.00 0.00
85 People's Center for Hemodialysis Care, Inc. Renal Therapy Solutions, Inc. Fellow subsidiary Sale of goods or services NA 0.50 0.00 0.00
86 People's Center for Hemodialysis Care, Inc. Kolff Dialysis Inc. Fellow subsidiary Sale of goods or services NA 0.00 0.00 0.00
87 Rizal Dialysis and Wellness Center, Inc. Nephrocare Health Care Services, Philippines Inc. Holding company Sale of goods or services NA 1.00 0.00 0.00
88 Renal Therapy Solutions, Inc. Nephrocare Health Care Services, Philippines Inc. Holding company Sale of goods or services NA 2.80 0.00 0.00
89 Renal Therapy Solutions, Inc. Cadiz Dialysis Hub, Inc. Fellow subsidiary Sale of goods or services NA 1.70 0.00 0.00
90 Renal Therapy Solutions, Inc. People's Center for Hemodialysis Care, Inc. Fellow subsidiary Sale of goods or services NA 0.20 0.00 0.00
91 Universe Kidney Care Center, Inc. Nephrocare Health Care Services, Philippines Inc. Holding company Sale of goods or services NA 1.50 0.00 0.00
92 Universe Kidney Care Center, Inc. Curis Cavite Renal Corporation Fellow subsidiary Sale of goods or services NA 0.00 0.00 0.00
93 Universe Kidney Care Center, Inc. AIZ Hemodialysis Center Inc. Fellow subsidiary Sale of goods or services NA 0.20 0.00 0.00
94 Universe Kidney Care Center, Inc. Kolff Dialysis Inc. Fellow subsidiary Sale of goods or services NA 0.40 0.00 0.00
95 Anram Medical Group Inc. Medical Experts Group and Associates, Inc. Fellow subsidiary Any other transaction Reimbursement of expenses NA 0.00 0.00 0.00
96 Renal Therapy Solutions, Inc. Rizal Dialysis and Wellness Center, Inc. Fellow subsidiary Any other transaction Reimbursement of expenses NA 0.10 0.00 0.00
97 AIZ Hemodialysis Center Inc. Rizal Dialysis and Wellness Center, Inc. Fellow subsidiary Any other transaction Reimbursement of expenses NA 0.30 0.00 0.00
98 Anram Medical Group Inc. Universe Kidney Care Center, Inc. Fellow subsidiary Any other transaction Reimbursement of expenses NA 0.30 0.00 0.00
99 Cadiz Dialysis Hub, Inc. Rizal Dialysis and Wellness Center, Inc. Fellow subsidiary Any other transaction Reimbursement of expenses NA 0.60 0.00 0.00
100 St. Margareth Dialysis and Biocare Center Inc. Nephrocare Health Care Services, Philippines Inc. Holding company Any other transaction Reimbursement of expenses NA 0.80 0.00 0.00
101 Carmona Dialysis System Inc. Bioregen Hemo Center Inc. Fellow subsidiary Any other transaction Reimbursement of expenses NA 1.00 0.00 0.00
102 Dialysis Asia and Patient Care Center Inc. Cadiz Dialysis Hub, Inc. Fellow subsidiary Any other transaction Reimbursement of expenses NA 1.10 0.00 0.00
103 Cadiz Dialysis Hub, Inc. Renal Therapy Solutions, Inc. Fellow subsidiary Any other transaction Reimbursement of expenses NA 2.50 0.00 0.00
104 Anram Medical Group Inc. Nephrocare Health Care Services, Philippines Inc. Holding company Any other transaction Reimbursement of expenses NA 4.10 0.00 0.00
105 Nephrocare Health Care Services, Philippines Inc. AIZ Hemodialysis Center Inc. Wholly owned subsidiary Any other transaction Reimbursement of expenses NA 12.90 0.00 0.00
106 Nephrocare Health Care Services, Philippines Inc. Medical Experts Group and Associates, Inc. Wholly owned subsidiary Any other transaction Reimbursement of expenses NA 18.60 0.00 0.00
107 Nephrocare Health Care Services, Philippines Inc. Universe Kidney Care Center, Inc. Wholly owned subsidiary Any other transaction Reimbursement of expenses NA 19.00 0.00 0.00
108 Nephrocare Health Care Services, Philippines Inc. Rizal Dialysis and Wellness Center, Inc. Wholly owned subsidiary Any other transaction Reimbursement of expenses NA 21.00 0.00 0.00
109 Nephrocare Health Care Services, Philippines Inc. Curis Hemodialysis Clinic, Inc. Wholly owned subsidiary Any other transaction Reimbursement of expenses NA 22.20 0.00 0.00
110 Nephrocare Health Care Services, Philippines Inc. Mega Health Dialysis Center, Inc. Wholly owned subsidiary Any other transaction Reimbursement of expenses NA 22.80 0.00 0.00
111 Nephrocare Health Care Services, Philippines Inc. Infini Care Health Systems Inc. Wholly owned subsidiary Any other transaction Reimbursement of expenses NA 23.40 0.00 0.00
112 Nephrocare Health Care Services, Philippines Inc. Bioregen Hemo Center Inc. Wholly owned subsidiary Any other transaction Reimbursement of expenses NA 24.60 0.00 0.00
113 Nephrocare Health Care Services, Philippines Inc. Cadiz Dialysis Hub, Inc. Wholly owned subsidiary Any other transaction Reimbursement of expenses NA 25.80 0.00 0.00
114 Nephrocare Health Care Services, Philippines Inc. Carmona Dialysis System Inc. Wholly owned subsidiary Any other transaction Reimbursement of expenses NA 30.00 0.00 0.00
115 Nephrocare Health Care Services, Philippines Inc. Curis Cavite Renal Corporation Wholly owned subsidiary Any other transaction Reimbursement of expenses NA 30.40 0.00 0.00
116 Nephrocare Health Care Services, Philippines Inc. People's Center for Hemodialysis Care, Inc. Wholly owned subsidiary Any other transaction Reimbursement of expenses NA 30.70 0.00 0.00
117 Nephrocare Health Care Services, Philippines Inc. Nephro Alliance Ventures, Inc. Wholly owned subsidiary Any other transaction Reimbursement of expenses NA 41.30 0.00 0.00
118 Nephrocare Health Care Services, Philippines Inc. Kolff Dialysis Inc. Wholly owned subsidiary Any other transaction Reimbursement of expenses NA 60.60 0.00 0.00
119 Nephrocare Health Care Services, Philippines Inc. Renal Therapy Solutions, Inc. Wholly owned subsidiary Any other transaction Reimbursement of expenses NA 156.20 0.00 0.00
120 Nephrocare Health Care Services, Philippines Inc. AIZ Hemodialysis Center Inc. Wholly owned subsidiary Any other transaction Management fee NA 15.00 0.00 0.00
121 Nephrocare Health Care Services, Philippines Inc. Infini Care Health Systems Inc. Wholly owned subsidiary Any other transaction Management fee NA 20.40 0.00 0.00
122 Nephrocare Health Care Services, Philippines Inc. Bioregen Hemo Center Inc. Wholly owned subsidiary Any other transaction Management fee NA 30.10 0.00 0.00
123 Nephrocare Health Care Services, Philippines Inc. Mega Health Dialysis Center, Inc. Wholly owned subsidiary Any other transaction Management fee NA 30.40 0.00 0.00
124 Nephrocare Health Care Services, Philippines Inc. Universe Kidney Care Center, Inc. Wholly owned subsidiary Any other transaction Management fee NA 34.60 0.00 0.00
125 Nephrocare Health Care Services, Philippines Inc. Medical Experts Group and Associates, Inc. Wholly owned subsidiary Any other transaction Management fee NA 35.70 0.00 0.00
126 Nephrocare Health Care Services, Philippines Inc. Carmona Dialysis System Inc. Wholly owned subsidiary Any other transaction Management fee NA 36.80 0.00 0.00
127 Nephrocare Health Care Services, Philippines Inc. Rizal Dialysis and Wellness Center, Inc. Wholly owned subsidiary Any other transaction Management fee NA 39.70 0.00 0.00
128 Nephrocare Health Care Services, Philippines Inc. Curis Hemodialysis Clinic, Inc. Wholly owned subsidiary Any other transaction Management fee NA 40.90 0.00 0.00
129 Nephrocare Health Care Services, Philippines Inc. People's Center for Hemodialysis Care, Inc. Wholly owned subsidiary Any other transaction Management fee NA 42.90 0.00 0.00
130 Nephrocare Health Care Services, Philippines Inc. Cadiz Dialysis Hub, Inc. Wholly owned subsidiary Any other transaction Management fee NA 49.70 0.00 0.00
131 Nephrocare Health Care Services, Philippines Inc. Curis Cavite Renal Corporation Wholly owned subsidiary Any other transaction Management fee NA 54.50 0.00 0.00
132 Nephrocare Health Care Services, Philippines Inc. Nephro Alliance Ventures, Inc. Wholly owned subsidiary Any other transaction Management fee NA 62.20 0.00 0.00
133 Nephrocare Health Care Services, Philippines Inc. Kolff Dialysis Inc. Wholly owned subsidiary Any other transaction Management fee NA 81.10 0.00 0.00
134 Nephrocare Health Care Services, Philippines Inc. Renal Therapy Solutions, Inc. Wholly owned subsidiary Any other transaction Management fee NA 391.90 0.00 0.00
135 Nephrocare Health Care Services, Philippines Inc. Curis Cavite Renal Corporation Wholly owned subsidiary Investment NA 15.40 0.00 0.00
136 Nephrocare Health Services International Pte, Singapore Nephrocare Health Services Saudi Arabia Joint Venture Investment 929.30 Approved 929.30 0.00 0.00 Loan 5.300 1 year Investment 0 Not applicale Unsecured Working capital
137 Nephrocare Health Services International Pte, Singapore NephroPlus Health Services Kazakhstan LLP Subsidiary Investment Note: The difference between the actual ratified value of INR 91.80 million and the transaction value of INR 92.59 million is attributable to foreign exchange rate fluctuations arising from the conversion of the transaction amount into Indian Rupees. 918.00 24-10-2026 925.90 0.00 0.00 Loan 5.6600 1 year Investment 0 Not applicale Unsecured Working capital and further Acquisition
138 Nephrocare Health Services International Pte, Singapore NephroPlus Health Services Kazakhstan LLP Subsidiary Loan NA 2,399.20 24-10-2026 2,217.80 0.00 2,270.70 Loan 5.6600 1 year Loan 7.1600 1 Unsecured (a) Financing the establishment, fit-out, equipping and commissioning of dialysis centers in Kazakhstan. (b) Acquisition of medical equipment, consumables and related healthcare assets; (c) Meeting initial working capital requirements of the Borrower's dialysis operations and (d) Such other capital or operational expenditures directly related to the Borrower's dialysis care business expansion and (e) For any other purpose with the written consent of the Lender.
139 Nephrocare Health Services International Pte, Singapore NephroPlus Health Services Kazakhstan LLP Subsidiary Interest received NA 25.70 24-10-2026 25.70 0.00 0.00
140 NephroPlus Health Services Kazakhstan LLP Dialysis Center of Almaty LLP Wholly owned subsidiary Loan NA 429.40 24-10-2026 53.40 0.00 53.70 Loan 7.1600 1 year Loan 17.00 1 Unsecured Company’s ongoing business operations.
141 NephroPlus Health Services Kazakhstan LLP Dialysis Center of Almaty LLP Wholly owned subsidiary Interest received NA 0.10 24-10-2026 0.10 0.00 0.00
142 NephroPlus Nephrocare Health Care Services, Philippines Inc. Step down subsidiary Any other transaction Receivables NA 0.00 168.60 289.10
143 NephroPlus AIZ Hemodialysis Centre Inc. Step down subsidiary Any other transaction Receivables NA 0.00 5.50 2.50
144 NephroPlus Anram Medical Group Inc. Step down subsidiary Any other transaction Receivables NA 0.00 0.00 0.00
145 NephroPlus Bioregen Hemo Center Inc. Step down subsidiary Any other transaction Receivables NA 0.00 9.50 5.60
146 NephroPlus Cadiz Dialysis Hub Inc. Step down subsidiary Any other transaction Receivables NA 0.00 20.10 6.60
147 NephroPlus Carmona Dialysis System Inc. Step down subsidiary Any other transaction Receivables NA 0.00 13.60 5.40
148 NephroPlus Curis Cavite Renal Corporation Step down subsidiary Any other transaction Receivables NA 0.00 21.40 7.50
149 NephroPlus Curis Hemodialysis Clinic Inc. Step down subsidiary Any other transaction Receivables NA 0.00 14.80 5.70
150 NephroPlus Dialysis Asia and Patient Care Center Inc. Step down subsidiary Any other transaction Receivables NA 0.00 0.00 0.00
151 NephroPlus Infini Care Health Systems Inc. Step down subsidiary Any other transaction Receivables NA 0.00 7.80 3.40
152 NephroPlus Kolff Dialysis Inc. Step down subsidiary Any other transaction Receivables NA 0.00 25.50 13.90
153 NephroPlus Medical Experts Group and Associates Inc. Step down subsidiary Any other transaction Receivables NA 0.00 15.80 5.10
154 NephroPlus Mega Health Dialysis Center Inc. Step down subsidiary Any other transaction Receivables NA 0.00 11.80 4.40
155 NephroPlus Nephro Alliance Ventures Inc. Step down subsidiary Any other transaction Receivables NA 0.00 24.40 8.90
156 NephroPlus People's Center For Hemodialysis Care Inc. Step down subsidiary Any other transaction Receivables NA 0.00 17.90 6.20
157 NephroPlus Renal Therapy Solutions Inc Step down subsidiary Any other transaction Receivables NA 0.00 154.10 57.20
158 NephroPlus Rizal dialysis and wellness centre OPC Step down subsidiary Any other transaction Receivables NA 0.00 14.70 5.90
159 NephroPlus St. Margareth Dialysis and Biocare Center Inc. Step down subsidiary Any other transaction Receivables NA 0.00 0.00 0.00
160 NephroPlus Universe Dialysis and Kidney Care Center Inc. Step down subsidiary Any other transaction Receivables NA 0.00 10.40 6.50
161 NephroPlus Nephrocare Health Services Nepal Pvt Ltd Wholly owned subsidiary Any other transaction Receivables NA 0.00 641.20 641.20
162 NephroPlus Nephrocare Health Services Saudi Arabia Joint Venture Any other transaction Receivables NA 0.00 0.00 13.70
163 NephroPlus Nephrocare Health Services International Pte, Singapore Wholly owned subsidiary Any other transaction Receivables NA 0.00 0.00 7.20
164 NephroPlus Nephrocare Health Services Central Asia Wholly owned subsidiary Any other transaction Receivables NA 0.00 186.60 241.80
165 Nephrocare Health Care Services, Philippines Inc. Bioregen Hemo Center Inc. Wholly owned subsidiary Any other transaction Payables NA 0.00 0.00 46.70
166 Nephrocare Health Care Services, Philippines Inc. Carmona Dialysis System Inc. Wholly owned subsidiary Any other transaction Payables NA 0.00 1.90 55.70
167 Bioregen Hemo Center Inc. Nephrocare Health Care Services, Philippines Inc. Holding company Any other transaction Payables NA 0.00 81.50 285.30
168 Nephrocare Health Care Services, Philippines Inc. AIZ Hemodialysis Centre Inc. Wholly owned subsidiary Any other transaction Payables NA 0.00 0.00 22.80
169 Nephrocare Health Care Services, Philippines Inc. Curis Hemodialysis Clinic Inc. Wholly owned subsidiary Any other transaction Payables NA 0.00 0.00 58.80
170 Nephrocare Health Care Services, Philippines Inc. Infini Care Health Systems Inc. Wholly owned subsidiary Any other transaction Payables NA 0.00 23.60 37.80
171 Nephrocare Health Care Services, Philippines Inc. Kolff Dialysis Inc. Wholly owned subsidiary Any other transaction Payables NA 0.00 0.00 101.10
172 Nephrocare Health Care Services, Philippines Inc. Nephro Alliance ventures Inc Wholly owned subsidiary Any other transaction Payables NA 0.00 146.40 78.40
173 AIZ Hemodialysis Centre Inc. Anram Medical Group Inc. Fellow subsidiary Any other transaction Payables NA 0.00 0.20 0.00
174 AIZ Hemodialysis Centre Inc. Bioregen Hemo Center Inc. Fellow subsidiary Any other transaction Payables NA 0.00 8.60 0.00
175 AIZ Hemodialysis Centre Inc. Curis Cavite Renal Corporation Fellow subsidiary Any other transaction Payables NA 0.00 0.20 0.00
176 AIZ Hemodialysis Centre Inc. Cadiz Dialysis Hub Inc. Fellow subsidiary Any other transaction Payables NA 0.00 0.20 0.00
177 AIZ Hemodialysis Centre Inc. Curis Hemodialysis Clinic Inc. Fellow subsidiary Any other transaction Payables NA 0.00 0.20 0.00
178 AIZ Hemodialysis Centre Inc. Dialysis Asia and Patient Care Center Inc. Fellow subsidiary Any other transaction Payables NA 0.00 0.20 0.00
179 AIZ Hemodialysis Centre Inc. Medical Experts Group and Associates Inc. Fellow subsidiary Any other transaction Payables NA 0.00 0.10 0.00
180 AIZ Hemodialysis Centre Inc. Mega Health Dialysis Center Inc. Fellow subsidiary Any other transaction Payables NA 0.00 0.10 0.00
181 AIZ Hemodialysis Centre Inc. Nephro Alliance ventures Inc Fellow subsidiary Any other transaction Payables NA 0.00 0.10 0.00
182 AIZ Hemodialysis Centre Inc. People's Center For Hemodialysis Care Inc. Fellow subsidiary Any other transaction Payables NA 0.00 0.20 0.00
183 AIZ Hemodialysis Centre Inc. Rizal Dialysis and Wellness Centre OPC Fellow subsidiary Any other transaction Payables NA 0.00 0.30 0.00
184 AIZ Hemodialysis Centre Inc. Renal Therapy Solutions INC Fellow subsidiary Any other transaction Payables NA 0.00 1.10 0.00
185 Anram Medical Group Inc. Nephrocare Health Care Services, Philippines Inc. Holding company Any other transaction Payables NA 0.00 340.10 269.50
186 Curis Cavite Renal Corporation Curis Hemodialysis Clinic Inc. Fellow subsidiary Any other transaction Payables NA 0.00 0.50 2.00
187 Curis Cavite Renal Corporation Nephrocare Health Care Services, Philippines Inc. Holding company Any other transaction Payables NA 0.00 216.60 443.90
188 Cadiz Dialysis Hub Inc. Nephrocare Health Care Services, Philippines Inc. Holding company Any other transaction Payables NA 0.00 92.80 328.30
189 Carmona Dialysis System Inc. Bioregen Hemo Center Inc. Fellow subsidiary Any other transaction Payables NA 0.00 35.20 70.80
190 Dialysis Asia and Patient Care Center Inc. Cadiz Dialysis Hub Inc. Fellow subsidiary Any other transaction Payables NA 0.00 0.50 1.10
191 Dialysis Asia and Patient Care Center Inc. Curis Hemodialysis Clinic Inc. Fellow subsidiary Any other transaction Payables NA 0.00 0.10 0.00
192 Dialysis Asia and Patient Care Center Inc. Nephrocare Health Care Services, Philippines Inc. Holding company Any other transaction Payables NA 0.00 165.10 136.20
193 Kolff Dialysis Inc. AIZ Hemodialysis Centre Inc. Fellow subsidiary Any other transaction Payables NA 0.00 1.00 2.30
194 Medical Experts Group and Associates Inc. Anram Medical Group Inc. Fellow subsidiary Any other transaction Payables NA 0.00 0.00 0.00
195 Medical Experts Group and Associates Inc. Cadiz Dialysis Hub Inc. Fellow subsidiary Any other transaction Payables NA 0.00 1.80 0.00
196 Medical Experts Group and Associates Inc. Nephrocare Health Care Services, Philippines Inc. Holding company Any other transaction Payables NA 0.00 90.60 197.90
197 Medical Experts Group and Associates Inc. People's Center For Hemodialysis Care Inc. Fellow subsidiary Any other transaction Payables NA 0.00 1.00 1.00
198 Mega Health Dialysis Center Inc. Curis Cavite Renal Corporation Fellow subsidiary Any other transaction Payables NA 0.00 0.80 0.90
199 Mega Health Dialysis Center Inc. Nephrocare Health Care Services, Philippines Inc. Holding company Any other transaction Payables NA 0.00 138.40 300.00
200 People's Center For Hemodialysis Care Inc. Nephrocare Health Care Services, Philippines Inc. Holding company Any other transaction Payables NA 0.00 59.60 301.30
201 Rizal Dialysis and Wellness Centre OPC Nephrocare Health Care Services, Philippines Inc. Holding company Any other transaction Payables NA 0.00 91.30 274.90
202 Renal Therapy Solutions INC Nephrocare Health Care Services, Philippines Inc. Holding company Any other transaction Payables NA 0.00 984.00 1,919.90
203 St. Margareth Dialysis and Biocare Center Inc. Bioregen Hemo Center Inc. Fellow subsidiary Any other transaction Payables NA 0.00 0.10 0.00
204 St. Margareth Dialysis and Biocare Center Inc. Cadiz Dialysis Hub Inc. Fellow subsidiary Any other transaction Payables NA 0.00 0.60 0.00
205 St. Margareth Dialysis and Biocare Center Inc. Medical Experts Group and Associates Inc. Fellow subsidiary Any other transaction Payables NA 0.00 0.90 0.00
206 St. Margareth Dialysis and Biocare Center Inc. Nephrocare Health Care Services, Philippines Inc. Holding company Any other transaction Payables NA 0.00 216.90 174.80
207 Universe Dialysis and Kidney Care Center Inc. AIZ Hemodialysis Centre Inc. Fellow subsidiary Any other transaction Payables NA 0.00 0.00 0.20
208 Universe Dialysis and Kidney Care Center Inc. Nephrocare Health Care Services, Philippines Inc. Holding company Any other transaction Payables NA 0.00 208.20 407.60
209 AIZ Hemodialysis Centre Inc. Carmona Dialysis System Inc. Fellow subsidiary Any other transaction Payables NA 0.00 0.50 0.00
210 Anram Medical Group Inc. Mega Health Dialysis Center Inc. Fellow subsidiary Any other transaction Payables NA 0.00 2.60 5.20
211 Anram Medical Group Inc. People's Center For Hemodialysis Care Inc. Fellow subsidiary Any other transaction Payables NA 0.00 0.70 1.40
212 Cadiz Dialysis Hub Inc. Renal Therapy Solutions INC Fellow subsidiary Any other transaction Payables NA 0.00 0.50 7.90
213 Medical Experts Group and Associates Inc. Mega Health Dialysis Center Inc. Fellow subsidiary Any other transaction Payables NA 0.00 0.20 0.20
214 Medical Experts Group and Associates Inc. Rizal Dialysis and Wellness Centre OPC Fellow subsidiary Any other transaction Payables NA 0.00 0.00 1.10
215 Mega Health Dialysis Center Inc. St. Margareth Dialysis and Biocare Center Inc. Fellow subsidiary Any other transaction Payables NA 0.00 0.40 0.80
216 Mega Health Dialysis Center Inc. Universe Dialysis and Kidney Care Center Inc. Fellow subsidiary Any other transaction Payables NA 0.00 0.90 1.60
217 People's Center For Hemodialysis Care Inc. Renal Therapy Solutions INC Fellow subsidiary Any other transaction Payables NA 0.00 0.00 0.50
218 Renal Therapy Solutions INC Anram Medical Group Inc. Fellow subsidiary Any other transaction Payables NA 0.00 0.00 0.00
219 St. Margareth Dialysis and Biocare Center Inc. Dialysis Asia and Patient Care Center Inc. Fellow subsidiary Any other transaction Payables NA 0.00 0.20 0.00
220 St. Margareth Dialysis and Biocare Center Inc. Anram Medical Group Inc. Fellow subsidiary Any other transaction Payables NA 0.00 0.10 0.00
221 Curis Hemodialysis Clinic Inc. Bioregen Hemo Center Inc. Fellow subsidiary Any other transaction Payables NA 0.00 0.10 0.00
222 Universe Dialysis and Kidney Care Center Inc. Curis Cavite Renal Corporation Fellow subsidiary Any other transaction Payables NA 0.00 0.70 0.00
223 Mega Health Dialysis Center Inc. Carmona Dialysis System Inc. Fellow subsidiary Any other transaction Payables NA 0.00 0.20 0.30
224 St. Margareth Dialysis and Biocare Center Inc. Carmona Dialysis System Inc. Fellow subsidiary Any other transaction Payables NA 0.00 0.00 0.00
225 Anram Medical Group Inc. Dialysis Asia and Patient Care Center Inc. Fellow subsidiary Any other transaction Payables NA 0.00 0.30 0.50
226 Mega Health Dialysis Center Inc. Dialysis Asia and Patient Care Center Inc. Fellow subsidiary Any other transaction Payables NA 0.00 0.10 0.00
227 Bioregen Hemo Center Inc. Infini Care Health Systems Inc. Fellow subsidiary Any other transaction Payables NA 0.00 0.00 0.80
228 Curis Hemodialysis Clinic Inc. Infini Care Health Systems Inc. Fellow subsidiary Any other transaction Payables NA 0.00 0.20 0.00
229 Mega Health Dialysis Center Inc. Kolff Dialysis Inc. Fellow subsidiary Any other transaction Payables NA 0.00 0.90 1.00
230 Universe Dialysis and Kidney Care Center Inc. Kolff Dialysis Inc. Fellow subsidiary Any other transaction Payables NA 0.00 0.30 0.40
231 Renal Therapy Solutions INC Medical Experts Group and Associates Inc. Fellow subsidiary Any other transaction Payables NA 0.00 0.40 1.20
232 Anram Medical Group Inc. Rizal Dialysis and Wellness Centre OPC Fellow subsidiary Any other transaction Payables NA 0.00 0.00 0.00
233 Dialysis Asia and Patient Care Center Inc. Renal Therapy Solutions INC Fellow subsidiary Any other transaction Payables NA 0.00 0.20 0.00
234 Rizal Dialysis and Wellness Centre OPC Renal Therapy Solutions INC Fellow subsidiary Any other transaction Payables NA 0.00 0.10 0.10
235 Infini Care Health Systems Inc. Carmona Dialysis System Inc. Fellow subsidiary Any other transaction Payables NA 0.00 0.20 0.30
236 AIZ Hemodialysis Centre Inc. Nephrocare Health Care Services, Philippines Inc. Holding company Any other transaction Payables NA 0.00 0.70 71.50
237 AIZ Hemodialysis Centre Inc. Universe Dialysis and Kidney Care Center Inc. Fellow subsidiary Any other transaction Payables NA 0.00 0.00 0.40
238 Anram Medical Group Inc. Medical Experts Group and Associates Inc. Fellow subsidiary Any other transaction Payables NA 0.00 0.60 0.60
239 Anram Medical Group Inc. Renal Therapy Solutions INC Fellow subsidiary Any other transaction Payables NA 0.00 0.40 0.00
240 Cadiz Dialysis Hub Inc. Mega Health Dialysis Center Inc. Fellow subsidiary Any other transaction Payables NA 0.00 0.20 0.00
241 Cadiz Dialysis Hub Inc. Rizal Dialysis and Wellness Centre OPC Fellow subsidiary Any other transaction Payables NA 0.00 1.10 1.60
242 Curis Hemodialysis Clinic Inc. Nephrocare Health Care Services, Philippines Inc. Holding company Any other transaction Payables NA 0.00 352.10 526.50
243 Carmona Dialysis System Inc. Curis Hemodialysis Clinic Inc. Fellow subsidiary Any other transaction Payables NA 0.00 0.20 0.00
244 Carmona Dialysis System Inc. Kolff Dialysis Inc. Fellow subsidiary Any other transaction Payables NA 0.00 0.60 1.20
245 Infini Care Health Systems Inc. Bioregen Hemo Center Inc. Fellow subsidiary Any other transaction Payables NA 0.00 6.10 12.50
246 Infini Care Health Systems Inc. Renal Therapy Solutions INC Fellow subsidiary Any other transaction Payables NA 0.00 0.00 0.00
247 Kolff Dialysis Inc. Bioregen Hemo Center Inc. Fellow subsidiary Any other transaction Payables NA 0.00 3.60 7.20
248 Kolff Dialysis Inc. Nephrocare Health Care Services, Philippines Inc. Holding company Any other transaction Payables NA 0.00 224.20 627.20
249 Mega Health Dialysis Center Inc. Renal Therapy Solutions INC Fellow subsidiary Any other transaction Payables NA 0.00 0.00 0.00
250 Nephro Alliance ventures Inc Anram Medical Group Inc. Fellow subsidiary Any other transaction Payables NA 0.00 0.10 0.20
251 People's Center For Hemodialysis Care Inc. Infini Care Health Systems Inc. Fellow subsidiary Any other transaction Payables NA 0.00 0.00 0.00
252 People's Center For Hemodialysis Care Inc. Kolff Dialysis Inc. Fellow subsidiary Any other transaction Payables NA 0.00 0.30 0.00
253 Renal Therapy Solutions INC Bioregen Hemo Center Inc. Fellow subsidiary Any other transaction Payables NA 0.00 0.00 0.00
254 Renal Therapy Solutions INC Carmona Dialysis System Inc. Fellow subsidiary Any other transaction Payables NA 0.00 0.00 0.00
255 Renal Therapy Solutions INC Nephro Alliance ventures Inc Fellow subsidiary Any other transaction Payables NA 0.00 0.80 1.60
256 Renal Therapy Solutions INC People's Center For Hemodialysis Care Inc. Fellow subsidiary Any other transaction Payables NA 0.00 2.60 5.20
257 AIZ Hemodialysis Centre Inc. Kolff Dialysis Inc. Fellow subsidiary Any other transaction Payables NA 0.00 0.00 0.30
258 Anram Medical Group Inc. Universe Dialysis and Kidney Care Center Inc. Fellow subsidiary Any other transaction Payables NA 0.00 0.00 0.30
259 Curis Cavite Renal Corporation Carmona Dialysis System Inc. Fellow subsidiary Any other transaction Payables NA 0.00 0.00 0.70
260 Curis Cavite Renal Corporation Mega Health Dialysis Center Inc. Fellow subsidiary Any other transaction Payables NA 0.00 0.00 0.00
261 Carmona Dialysis System Inc. Curis Cavite Renal Corporation Fellow subsidiary Any other transaction Payables NA 0.00 0.00 1.20
262 Carmona Dialysis System Inc. Mega Health Dialysis Center Inc. Fellow subsidiary Any other transaction Payables NA 0.00 0.00 0.70
263 Carmona Dialysis System Inc. Nephrocare Health Care Services, Philippines Inc. Holding company Any other transaction Payables NA 0.00 0.00 126.10
264 Carmona Dialysis System Inc. Universe Dialysis and Kidney Care Center Inc. Fellow subsidiary Any other transaction Payables NA 0.00 0.00 0.10
265 Infini Care Health Systems Inc. Curis Hemodialysis Clinic Inc. Fellow subsidiary Any other transaction Payables NA 0.00 0.00 0.90
266 Infini Care Health Systems Inc. Nephrocare Health Care Services, Philippines Inc. Holding company Any other transaction Payables NA 0.00 0.00 179.80
267 Kolff Dialysis Inc. Universe Dialysis and Kidney Care Center Inc. Fellow subsidiary Any other transaction Payables NA 0.00 0.00 0.20
268 Medical Experts Group and Associates Inc. Renal Therapy Solutions INC Fellow subsidiary Any other transaction Payables NA 0.00 0.00 0.80
269 Nephro Alliance ventures Inc Nephrocare Health Care Services, Philippines Inc. Holding company Any other transaction Payables NA 0.00 0.00 7.40
270 Nephrocare Health Care Services, Philippines Inc. Anram Medical Group Inc. Wholly owned subsidiary Any other transaction Payables NA 0.00 0.00 1.30
271 Nephrocare Health Care Services, Philippines Inc. Curis Cavite Renal Corporation Wholly owned subsidiary Any other transaction Payables NA 0.00 0.00 109.30
272 Nephrocare Health Care Services, Philippines Inc. Cadiz Dialysis Hub Inc. Wholly owned subsidiary Any other transaction Payables NA 0.00 0.00 45.80
273 Nephrocare Health Care Services, Philippines Inc. Medical Experts Group and Associates Inc. Wholly owned subsidiary Any other transaction Payables NA 0.00 0.00 69.50
274 Nephrocare Health Care Services, Philippines Inc. Mega Health Dialysis Center Inc. Wholly owned subsidiary Any other transaction Payables NA 0.00 0.00 51.50
275 Nephrocare Health Care Services, Philippines Inc. People's Center For Hemodialysis Care Inc. Wholly owned subsidiary Any other transaction Payables NA 0.00 0.00 89.50
276 Nephrocare Health Care Services, Philippines Inc. Rizal Dialysis and Wellness Centre OPC Wholly owned subsidiary Any other transaction Payables NA 0.00 0.00 53.20
277 Nephrocare Health Care Services, Philippines Inc. Renal Therapy Solutions INC Wholly owned subsidiary Any other transaction Payables NA 0.00 0.00 446.60
278 Nephrocare Health Care Services, Philippines Inc. Universe Dialysis and Kidney Care Center Inc. Wholly owned subsidiary Any other transaction Payables NA 0.00 0.00 56.90
279 People's Center For Hemodialysis Care Inc. Medical Experts Group and Associates Inc. Fellow subsidiary Any other transaction Payables NA 0.00 0.00 0.00
280 Renal Therapy Solutions INC Cadiz Dialysis Hub Inc. Fellow subsidiary Any other transaction Payables NA 0.00 0.00 3.00
281 Universe Dialysis and Kidney Care Center Inc. Mega Health Dialysis Center Inc. Fellow subsidiary Any other transaction Payables NA 0.00 0.00 0.00
282 NephroPlus Nephrocare Health Care Services, Philippines Inc. Step down subsidiary Any other transaction Issuance of Corporate Guarantee in favour of Citibank N.A. on behalf of the Company’s step-down wholly owned subsidiary, NHCSPI, to secure credit facilities availed by the subsidiary. NA 5,246.20 0.00 5,246.20
283 NephroPlus Nephrocare Health Services International Pte, Singapore Wholly owned subsidiary Any other transaction Providing collateral/security support in favour of HSBC for the benefit of the Company’s overseas wholly owned subsidiary, NHSI, to secure fund-based and/or non-fund-based credit facilities. NA 3,126.00 0.00 3,359.00
284 NephroPlus Nephrocare Health Services International Pte, Singapore Wholly owned subsidiary Any other transaction Providing collateral/security support in favour of Citibank N.A. for the benefit of the Company’s overseas wholly owned subsidiary, NHSI, to secure fund-based and/or non-fund-based credit facilities. NA 3,121.70 0.00 3,167.00
285 NephroPlus Nephrocare Health Care Services, Philippines Inc. Step down subsidiary Any other transaction Provided corporate guarantees in favour of HSBC Bank to facilitate working capital and banking arrangements of the Company’s wholly owned subsidiary, NA 0.00 7,674.20 7,674.20
286 NephroPlus Nephrocare Health Services Central Asia Wholly owned subsidiary Any other transaction Issuance of corporate guarantee in favour of Asian Development Bank (ADB) on behalf of the Company’s overseas subsidiary, Nephrocare Health Services Central Asia. NA 0.00 11,267.70 11,267.70
287 NephroPlus Nephrocare Health Services Central Asia Wholly owned subsidiary Any other transaction Equity Investments in Wholly owned subsidiary NA 0.00 1,905.70 1,905.70
288 NephroPlus Nephrocare Health Services International Pte, Singapore Wholly owned subsidiary Any other transaction Equity Investments in Wholly owned subsidiary NA 0.00 18,204.00 18,204.00
289 NephroPlus Nephrocare Health Services Nepal Pvt Ltd Wholly owned subsidiary Any other transaction Equity Investments in Wholly owned subsidiary NA 0.00 308.60 308.60
290 Nephrocare Health Services International Pte, Singapore Nephrocare Health Care Services, Philippines Inc. Wholly owned subsidiary Any other transaction Equity Investments in Wholly owned subsidiary NA 0.00 16,805.30 16,805.30
291 Nephrocare Health Care Services, Philippines Inc. Anram Medical Group Inc. Wholly owned subsidiary Any other transaction Equity Investments in Wholly owned subsidiary NA 0.00 1,095.00 1,095.00
292 Nephrocare Health Care Services, Philippines Inc. Cadiz Dialysis Hub Inc. Wholly owned subsidiary Any other transaction Equity Investments in Wholly owned subsidiary NA 0.00 337.80 337.80
293 Nephrocare Health Care Services, Philippines Inc. Dialysis Asia and Patient Care Inc. Wholly owned subsidiary Any other transaction Equity Investments in Wholly owned subsidiary NA 0.00 184.20 184.20
294 Nephrocare Health Care Services, Philippines Inc. Curis Hemodialysis Clinic Inc. Wholly owned subsidiary Any other transaction Equity Investments in Wholly owned subsidiary NA 0.00 322.40 322.40
295 Nephrocare Health Care Services, Philippines Inc. Mega Health Dialysis Centre Inc. Wholly owned subsidiary Any other transaction Equity Investments in Wholly owned subsidiary NA 0.00 384.10 384.10
296 Nephrocare Health Care Services, Philippines Inc. Renal Therapy Solution Inc. Wholly owned subsidiary Any other transaction Equity Investments in Wholly owned subsidiary NA 0.00 1,980.50 1,980.50
297 Nephrocare Health Care Services, Philippines Inc. Curis Cavity Renal Corporation Inc. Wholly owned subsidiary Any other transaction Equity Investments in Wholly owned subsidiary NA 0.00 437.50 452.90
298 Nephrocare Health Care Services, Philippines Inc. Universal Dialysis and Kidney Care Centre Inc. Wholly owned subsidiary Any other transaction Equity Investments in Wholly owned subsidiary NA 0.00 387.60 387.60
299 Nephrocare Health Care Services, Philippines Inc. St. Margareth Dialysis and Biocare Centre Inc. Wholly owned subsidiary Any other transaction Equity Investments in Wholly owned subsidiary NA 0.00 280.40 280.40
300 Nephrocare Health Care Services, Philippines Inc. People Centre for Hemodialysis Care Inc. Wholly owned subsidiary Any other transaction Equity Investments in Wholly owned subsidiary NA 0.00 237.60 237.60
301 Nephrocare Health Care Services, Philippines Inc. Medical Expert Group and Associates Inc. Wholly owned subsidiary Any other transaction Equity Investments in Wholly owned subsidiary NA 0.00 856.70 856.70
302 Nephrocare Health Care Services, Philippines Inc. Rizal Dialysis and Wellness Centre Wholly owned subsidiary Any other transaction Equity Investments in Wholly owned subsidiary NA 0.00 365.40 365.40
303 Nephrocare Health Care Services, Philippines Inc. AIZ Hemodialysis Centre Inc. Wholly owned subsidiary Any other transaction Equity Investments in Wholly owned subsidiary NA 0.00 534.40 534.40
304 Nephrocare Health Care Services, Philippines Inc. Bioregen Hemo Center Inc. Wholly owned subsidiary Any other transaction Equity Investments in Wholly owned subsidiary NA 0.00 364.50 364.50
305 Nephrocare Health Care Services, Philippines Inc. Carmona Dialysis System Inc. Wholly owned subsidiary Any other transaction Equity Investments in Wholly owned subsidiary NA 0.00 512.30 512.30
306 Nephrocare Health Care Services, Philippines Inc. Infini Care Health Systems Inc. Wholly owned subsidiary Any other transaction Equity Investments in Wholly owned subsidiary NA 0.00 316.70 316.70
307 Nephrocare Health Care Services, Philippines Inc. Kolff Dialysis Inc. Wholly owned subsidiary Any other transaction Equity Investments in Wholly owned subsidiary NA 0.00 932.30 932.30
308 Nephrocare Health Care Services, Philippines Inc. Nephro Alliance Ventures, Inc. Wholly owned subsidiary Any other transaction Equity Investments in Wholly owned subsidiary NA 0.00 1,602.00 1,602.00
309 Nephrocare Health Services International Pte, Singapore Nephro Plus Kidney Services Company Wholly owned subsidiary Any other transaction Equity Investments in Wholly owned subsidiary NA 0.00 25.80 25.80
Total value of transaction during the reporting period 21,636.70